New ETF Book by Larry Connors - Click here to read more
"We now have a bold, new innovation to address the issues of downtime when a customer is ready to replace older technology with state-of-the-art treatment solutions," says Jay Hoey, President and CEO of Elekta North America. "The TRV makes it easy to expand, modify or upgrade a radiation treatment facility and most importantly, it further expedites patient services and operational revenue streams."
Many radiation oncology centers looking to upgrade their linear accelerators and treatment planning solutions are concerned about downtime for patients and staff. Currently, centers and hospitals must displace patients to alternate locations or run therapies into the late nights or early mornings. The RAD solution duplicates the center or hospital's processes in a compact and temporary package allowing patient therapy to continue while the new treatment system is installed. Elekta and RAD customers will benefit from workflow improvements before, during and after renovations.
"The TRV technology is based on RAD's patented Vault system which has been deployed for more than five years in the U.K., Canada, U.S. and now Mexico," states company President John J. Lefkus III. "This is a first for radiation centers seeking to upgrade equipment, while maintaining patient therapies during the upgrade. TRV provides effective and speedy solutions unmatched by any radiation shielding technology and Elekta sees the positive benefits for their customers."
RAD's President further states, "We expect to have a fleet of TRVs in service to handle the hundreds of centers paralyzed from upgrading because they are unable shutdown and deprive 30 or more patients a day from receiving cancer therapy."
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
About RAD Technology Medical Systems LLC
RAD provides revolutionary turnkey and relocatable radiation containment systems for cancer treatment facilities. RTMS designs and builds proprietary technology for temporary, permanent or bridge facilities. RTMS's products are available for sale and lease. For further information, visit www.rad-technology.com.
SOURCE Elekta
http://www.elekta.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
